CLINICAL_TRIALS
withdrawal
· 2025-04-08
Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis [Phase 1]
Summary
Phase 1 trial evaluating the safety of intravenous infusion of cultured allogeneic umbilical cord-derived mesenchymal stem cells for osteoporosis has been withd…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Osteoporosis | Phase 1 | Status: WITHDRAWN